Detalhe da pesquisa
1.
Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases.
Mol Ther;
32(3): 637-645, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38204163